Document is current
Any future updates will be listed below
-
Authors
Xie, Pujun https://orcid.org/0000-0001-8456-3801
Li, Yan
Lamon, Gaëlle
Kuang, Huihui
Wang, Da-Neng https://orcid.org/0000-0002-6496-4699
Traaseth, Nathaniel J. https://orcid.org/0000-0002-1185-6088
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI165782)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI108889)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI165782)
NSF | BIO | Division of Molecular and Cellular Biosciences (1902449)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK135088)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS108151)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM121994)
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 24 November 2024
First Online: 2 January 2025
Competing interests
: D.N.W. and N.J.T. are listed as inventors of a patent application filed by New York University on NorA inhibitors (WO2023014970A2). The other authors declare no competing interests.
